V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005024 | 220001973 | 1.61 | null | Disease modification (D) | 2014-01-21 | 2014-01-21 | LI-1 TRIAL | Y | N | 220027297 | TRIAL |
| 220005025 | 220001974 | null | 74.4 | Curative (C) | null | 2015-01-21 | Trial Unspecified | N | N | 220027299 | TRIAL |
| 220005026 | 220001974 | 1.63 | null | Palliative (P) | 2018-05-17 | 2018-06-03 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027299 | CYTARABINE |
| 220005027 | 220001975 | 1.69 | 0 | Palliative (P) | 2013-05-26 | 2013-05-31 | Cytarabine Low Dose | N | null | 220027303 | CYTARABINE |
| 220005028 | 220001975 | 1.72 | 68 | Curative (C) | 2014-01-08 | 2014-01-08 | Trial Unspecified | Y | N | 220027303 | TRIAL |
| 220005029 | 220001975 | 0 | 67.3 | Curative (C) | 2013-10-13 | 2013-10-13 | LI-1 TRIAL | 1 | N | 220027303 | TRIAL |
| 220005030 | 220018714 | null | 55 | Curative (C) | 2015-05-22 | 2015-05-22 | AML17 TRIAL | N | N | 220027313 | AML17 TRIAL |
| 220005031 | 220018714 | 1.85 | 77.4 | Curative (C) | null | 2017-07-22 | Trial Unspecified | Y | null | 220027313 | TRIAL |
| 220005032 | 220001976 | null | null | Palliative (P) | 2014-07-30 | 2014-07-30 | CYTARABINE | 2 | N | 220027315 | CYTARABINE |
| 220005033 | 220001977 | null | 0 | Curative (C) | 2014-01-15 | 2014-01-16 | Cytarabine Low Dose | 2 | N | 220027316 | CYTARABINE |
| 220005034 | 220001977 | 1.71 | null | Palliative (P) | 2015-09-15 | 2015-09-21 | CYTARABINE | N | N | 220027316 | CYTARABINE |
| 220005035 | 220001977 | 1.7 | 73 | Curative (C) | 2014-03-10 | 2014-03-10 | AML17 TRIAL | N | N | 220027316 | AML17 TRIAL |
| 220005036 | 220018715 | null | null | null | 2016-04-30 | 2016-05-01 | Cytarabine Low Dose | N | N | 220027320 | CYTARABINE |
| 220005037 | 220018715 | null | 60 | Palliative (P) | 2017-08-15 | 2017-08-15 | Trial Unspecified | 01 | N | 220027320 | TRIAL |
| 220005038 | 220021210 | 1.81 | 3.3 | Palliative (P) | 2014-06-13 | 2014-06-14 | Cytarabine Low Dose | 02 | N | 220027327 | CYTARABINE |
| 220005041 | 220001979 | 1.8 | 0 | Palliative (P) | 2014-10-27 | 2014-10-27 | Cytarabine Low Dose | N | N | 220027332 | CYTARABINE |
| 220005042 | 220001979 | 1.73 | 73 | Curative (C) | 2014-12-15 | 2014-12-17 | Trial Unspecified | 01 | null | 220027332 | TRIAL |
| 220005043 | 220015901 | 1.57 | 83 | Curative (C) | 2013-05-19 | 2013-05-20 | AML17 TRIAL | N | null | 220027337 | AML17 TRIAL |
| 220005044 | 220001980 | null | 70 | Curative (C) | 2014-08-26 | 2014-08-26 | AML17 TRIAL | 1 | N | 220027345 | AML17 TRIAL |
| 220005045 | 220001980 | 1.57 | null | Curative (C) | 2015-03-04 | 2015-03-05 | AML17 TRIAL | Y | N | 220027345 | AML17 TRIAL |
| 220005046 | 220001980 | null | 79.8 | Curative (C) | 2015-12-01 | 2015-12-01 | CYTARABINE | 1 | null | 220027345 | CYTARABINE |
| 220005047 | 220001980 | 1.62 | null | Palliative (P) | 2014-02-20 | 2014-02-22 | Cytarabine Low Dose | 2 | N | 220027345 | CYTARABINE |
| 220005048 | 220001981 | 1.65 | null | Disease modification (D) | 2015-04-25 | 2015-04-25 | AML17 TRIAL | 01 | N | 220027349 | AML17 TRIAL |
| 220005049 | 220001981 | 1.64 | null | Palliative (P) | null | 2016-03-26 | Cytarabine Low Dose | N | N | 220027349 | CYTARABINE |
| 220005052 | 220001983 | 1.8 | null | Disease modification (D) | 2015-04-30 | 2015-04-30 | CYTARABINE | 02 | null | 220027353 | CYTARABINE |
| 220005053 | 220001983 | 1.54 | 76 | Not known (9) | 2011-11-01 | 2013-08-21 | AML17 TRIAL | N | N | 220027353 | AML17 TRIAL |
| 220005054 | 220001983 | 1.56 | null | Not known (9) | 2013-03-07 | 2013-03-21 | AML17 TRIAL | N | N | 220027353 | AML17 TRIAL |
| 220005055 | 220001984 | 1.75 | 26.1 | Palliative (P) | 2014-12-08 | 2014-12-08 | CYTARABINE | null | null | 220027359 | CYTARABINE |
| 220005056 | 220001985 | null | 119.8 | Curative (C) | null | 2013-03-13 | AML17 TRIAL | null | null | 220027361 | AML17 TRIAL |
| 220005057 | 220001985 | 0 | 88.9 | Palliative (P) | null | 2014-10-30 | Trial Unspecified | Y | null | 220027361 | TRIAL |
| 220005058 | 220001985 | 1.55 | 106 | Disease modification (D) | 2013-09-27 | 2013-09-27 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027361 | CYTARABINE |
| 220005059 | 220001985 | 1.79 | 64 | Curative (C) | 2017-05-21 | 2017-05-22 | AML17 TRIAL | 1 | null | 220027361 | AML17 TRIAL |
| 220005060 | 220001985 | 1.73 | null | Curative (C) | 2013-08-10 | 2013-08-13 | CYTARABINE | N | N | 220027361 | CYTARABINE |
| 220005061 | 220001985 | 1.65 | 77.5 | Disease modification (D) | 2014-08-05 | 2014-08-15 | AML17 TRIAL | 02 | N | 220027361 | AML17 TRIAL |
| 220005062 | 220001986 | null | 85.5 | Curative (C) | 2014-09-22 | 2014-09-22 | AML17 TRIAL | Y | null | 220027371 | AML17 TRIAL |
| 220005063 | 220001987 | 1.79 | 119.5 | Curative (C) | 2015-05-07 | 2015-05-07 | Trial Unspecified | 1 | null | 220027373 | TRIAL |
| 220005064 | 220011045 | 1.59 | 46.4 | Palliative (P) | null | 2016-08-15 | Cytarabine low (10to20mg/m2) IV/SC | 2 | Y | 220027377 | CYTARABINE |
| 220005065 | 220011045 | 1.62 | 81.9 | Curative (C) | 2013-11-28 | 2013-11-28 | Cytarabine Low Dose | N | N | 220027377 | CYTARABINE |
| 220005066 | 220001988 | 1.7 | null | Palliative (P) | 2014-05-01 | 2014-05-02 | Cytarabine Low Dose | 02 | N | 220027380 | CYTARABINE |
| 220005067 | 220001989 | 1.66 | 89.1 | Palliative (P) | 2014-06-15 | 2014-06-15 | Trial Unspecified | 01 | N | 220027384 | TRIAL |
| 220005068 | 220001989 | null | 0 | Palliative (P) | 2015-04-29 | 2015-04-29 | Cytarabine Low Dose | 02 | N | 220027384 | CYTARABINE |
| 220005069 | 220015906 | null | 96.2 | Not known (9) | 2015-10-03 | 2015-10-06 | Trial Unspecified | Y | N | 220027390 | TRIAL |
| 220005070 | 220001990 | 1.73 | 86 | Curative (C) | 2017-06-21 | 2017-06-23 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027394 | CYTARABINE |
| 220005071 | 220001990 | null | 74 | Curative (C) | 2017-03-25 | 2017-03-28 | AML17 TRIAL | Y | N | 220027394 | AML17 TRIAL |
| 220005072 | 220001991 | 1.67 | 78 | Curative (C) | 2017-08-13 | 2017-08-13 | Trial Unspecified | Y | N | 220027396 | TRIAL |
| 220005073 | 220001991 | 1.65 | 75.3 | Curative (C) | 2016-12-31 | 2017-01-11 | LI-1 TRIAL | Y | N | 220027396 | TRIAL |
| 220005074 | 220001992 | 1.76 | 88 | Curative (C) | 2017-09-04 | 2017-09-05 | AML17 TRIAL | 01 | N | 220027398 | AML17 TRIAL |
| 220005075 | 220001992 | 1.56 | 58.8 | Palliative (P) | 2016-05-19 | 2016-05-19 | Cytarabine Low Dose | N | N | 220027398 | CYTARABINE |
| 220005076 | 220001992 | 1.5 | 105 | Palliative (P) | 2014-01-15 | 2014-01-18 | Cytarabine Low Dose | N | N | 220027398 | CYTARABINE |
| 220005080 | 220018718 | null | null | Curative (C) | 2015-04-10 | 2015-04-22 | Cytarabine Low Dose | N | N | 220027410 | CYTARABINE |